Affiliation:
1. Department of Pharmacology, the Second Affiliated Hospital, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou 310058, China
2. Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou 310053, China
Abstract
Schizophrenia is a serious mental disorder, and existing antipsychotic drugs show limited efficacy and cause unwanted side effects. The development of glutamatergic drugs for schizophrenia is currently challenging. Most functions of histamine in the brain are mediated by the histamine H
1
receptor; however, the role of the H
2
receptor (H
2
R) is not quite clear, especially in schizophrenia. Here, we found that expression of H
2
R in glutamatergic neurons of the frontal cortex was decreased in schizophrenia patients. Selective knockout of the H
2
R gene (
Hrh2
) in glutamatergic neurons (
CaMKIIα-Cre; Hrh2
fl/fl
) induced schizophrenia-like phenotypes including sensorimotor gating deficits, increased susceptibility to hyperactivity, social withdrawal, anhedonia, and impaired working memory, as well as decreased firing of glutamatergic neurons in the medial prefrontal cortex (mPFC) in in vivo electrophysiological tests. Selective knockdown of H
2
R in glutamatergic neurons in the mPFC but not those in the hippocampus also mimicked these schizophrenia-like phenotypes. Furthermore, electrophysiology experiments established that H
2
R deficiency decreased the firing of glutamatergic neurons by enhancing the current through hyperpolarization-activated cyclic nucleotide-gated channels. In addition, either H
2
R overexpression in glutamatergic neurons or H
2
R agonism in the mPFC counteracted schizophrenia-like phenotypes in an MK-801-induced mouse model of schizophrenia. Taken together, our results suggest that deficit of H
2
R in mPFC glutamatergic neurons may be pivotal to the pathogenesis of schizophrenia and that H
2
R agonists can be regarded as potentially efficacious medications for schizophrenia therapy. The findings also provide evidence for enriching the conventional glutamate hypothesis for the pathogenesis of schizophrenia and improve the understanding of the functional role of H
2
R in the brain, especially in glutamatergic neurons.
Funder
National Natural Science Foundation of China
MOST | National Key Research and Development Program of China
Publisher
Proceedings of the National Academy of Sciences
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献